Associated Papers
Tiny genome with big impact: mitochondrial DNA in cardiovascular health.
Yang Y et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2025
Next-generation sequencing for pediatric-onset neuromuscular disorders unresolved by conventional diagnostic methods.
Kulsirichawaroj P et al.
Pediatric Research, 2025
40494860 (PubMed )
Supplement: 41390_2025_4160_MOESM1_ESM.pdf
Mitochondrial Mutation Leads to Cardiomyocyte Hypertrophy by Disruption of Mitochondria-Associated ER Membrane.
Yu M et al.
Cell Proliferation, 2025
To prevent sudden death in m.3243A>G carriers, comprehensive neurologic, cardiac, and pulmological examinations are required.
Mehri S et al.
Cardiology in the Young, 2024
Bilateral deafness, diabetes, and different types of cardiomyopathy in family members with m.3243A > g mutation: a case report.
Seiler F et al.
European Heart Journal. Case Reports, 2023
Adult-onset MELAS syndrome in a 51-year-old woman without typical clinical manifestations: a case report.
Lee SH et al.
European Heart Journal. Case Reports, 2023
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Chakrabarty S et al.
Journal of Neurology, 2021
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.
Arbustini E et al.
Journal of the American College of Cardiology, 2013
The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation.
Arbustini E et al.
Global Heart, 2013
Select a paper to view details